baber/WOPTO huggingface dataset:
Patent CA-2678402-A1 (CA)
Inventor: LEE ALAN SIAN GHEE
IPC: E04B5/00
Filed: 2008-02-15
Abstract: A support means (100) for engaging a batten, joist or the like (200), includes a circular rotatable plate (110). The plate has depending legs (112) for engaging the support means with a support structure such as a pedestal jack or the like, in a manner which allows the support means to be rotated about a vertical axis passing through the centre (111) of the plate. The support means (100) further includes two opposed upstanding walls (120, 122) defining a gap for receiving the batten, joist or the like. The walls are disposed either side of the axis and extend from a centremost position closest to the axis (111) to a distal end farthest from the axis. The walls are at least partly convex, and the gap between the walls measured in a direction perpendicular to tangents to the walls decreases from the centremost part of the wall to the distal end of the wall, so that for a joist batten or the like having a predetermined width and positioned between the walls (120, 122), rotation of the support means about the axis in one sense causes the walls (120, 122) to tend to abut edges of the joist and in the opposite sense causes the walls (120, 122) to tend to move away from the edges of the joist. The walls define apertures (129) for fastening the walls to the joist with nails, screws or the like.
Patent CA-2682809-A1 (CA)
Inventor: O'HAGAN BRIAN ROBERT
IPC: B65D43/16
Filed: 2003-03-17
Abstract: A method and a tool (562) for forming a tray (100) or container (478) which may be hermetically sealed having a flange encapsulated by or formed from injection-mold material. The tray (100) has a flange (116) extending outwardly from a sidewall (114) of the tray, and containing irregularities induced by the creation of the tray (100). An encapsulating material surrounds the flange (116) in substantially uniformly thick manner, and along with the flange (116) defines an encapsulated rim (124). The encapsulating material is generally a plastic such as polyolefin, nylon, or polyethylene, but may also be made from other materials. This encapsulating material covers a portion of the flange (116) and extends a set distance from the flange's (116) outer edge.
Patent CA-2684155-A1 (CA)
Title: Improved bitumen extraction process
Inventor: MOFFETT ROBERT HARVEY
IPC: C10G1/04
Filed: 2009-10-29
Abstract: A process for the extraction and recovery of bitumen from oil sands and a process for the treatment of tailings are disclosed. Bitumen is recovered in a process comprising contacting a polysilicate microgel with an ore sand oil to produce a froth comprising bitumen and a tailings stream comprising water, sand and clay fines. Preferably the tailings stream is dewatered and recovered water may be recycled to the extraction process. Polysilicate microgel may be carried through to a dewatering step and enhances flocculation in dewatering said tailings.
Patent CA-2684601-A1 (CA)
Inventor: GAN DAVID
IPC: A61K8/97
Filed: 2008-03-14
Abstract: Disclosed is a composition comprising at least two of the following ingredients: Magnolia extract, honokiol, humulus lupulus extract, hesperidin methyl chalcone, gotu kola, dipeptide valyl-tryptophane, palmitoyl tetrapeptide-3, corylus avellana bud extract, centella asiatica extract, cucumis sativa extract, morus alba extract, hibiscus sabdariffa flower extract, vitis vinifera extract, ascorbyl glucoside, citrus medica limonum extract, avena sativa kernel extract, hydrolyzed soy protein, aniseed myrtle extract, tasmania lanceolata leaf extract, artemisia abrotanum extract, or citrus grandis fruit extract or any combination thereof. Also disclosed are methods of treating skin conditions by topically applying the composition to skin.
Patent CA-2688362-A1 (CA)
Inventor: BLANCHETTE FRANCOIS
IPC: B65D85/30
Filed: 2009-12-14
Abstract: A container for receiving frangible items comprises a sheet of polymer formed into a base portion having a plurality of item-receiving cavities for supporting frangible items.                                                        A  cover portion has an item-covering concavity for covering the frangible items. A first hinge portion is positioned between a first longitudinal edge of the base portion and the cover portion for rotating the cover portion onto the base portion to hold the frangible items captive in the item-receiving cavities.                           The first hinge portion comprises a pair of longitudinal grooves formed into the first hinge portion and extending parallel to the first longitudinal edge of the base portion, with a web defined between the longitudinal grooves, and a hinge-reinforcement wall at at least one end of the longitudinal grooves. A fold line is formed in the web and in the hinge-reinforcement wall when the cover portion is rotated onto the base portion.
Patent CA-2689563-A1 (CA)
Title: 17.beta.-cyano-18a-homo-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative
Inventor: PRELLE KATJA
IPC: C07J53/00
Filed: 2008-06-04
Abstract: The 17ß-cyano-18a-homo-19-nor-androst-4-ene derivatives of the present invention have gestagenic activity. They have the general chemical formula (1), in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO2R, wherein R is hydrogen or C1-C4 alkyl, R4 is hydrogen or halogen and in addition either: R6a, R6b together form methylene or 1,2 ethanediyl or R6a is hydrogen and R6b is selected from the group comprising hydrogen, methyl and hydroxymethylene, and R7 is selected from the group comprising hydrogen, C1-C4 alkyl, C2-C3 alkenyl and cyclopropyl, or: R6a is hydrogen and R6b and R7 together either form methylene, or are omitted, whereby a double bond is formed between C6 and C7, R9 andR10 are hydrogen, or are omitted, whereby a double bond is formed between C9 and C10, R15 and R16 are hydrogen or together form methylene, R17 is selected from the group comprising hydrogen, C1-C4 alkyl and aIIyI, at least one of the substituents R4, R6a, R6b, R7, R15, R16 and R17 not being hydrogen, or R6b and R7 being omitted, whereby a double bond is formed between C6 and C7,or are omitted, whereby a double bond is formed between C1 and C2. The derivatives also comprise the solvates, hydrates, stereoisomers, diastereomers, enantiomers and salts of the aforementioned substances.
Patent CA-2690863-A1 (CA)
Inventor: LU CHEN
IPC: C08L39/00
Filed: 2008-06-13
Abstract: Storage-stable glyoxalated polyacrylamide polymers and high solids aqueous compositions formulated with them are described. These glyoxalated polyacrylamide compositions can be used as additives for papermaking, providing paper with good dry and temporary wet strength, and increasing papermaking de-watering rates.
Patent CA-2691054-A1 (CA)
Inventor: PEPYS MARK BRIAN
IPC: A61K31/401
Filed: 2008-06-27
Abstract: The invention describes the use of a compound which depletes serum amyloid P  component from the circulation, in combination with an antibody specific for serum amyloid P component, for the treatment or prophylaxis of amyloidosis.
Patent CA-2691642-A1 (CA)
Title: Reactor for carrying out a three-phase reaction of a liquid phase and a gaseous phase over a fixed catalyst bed
Inventor: ISELBORN STEFAN
IPC: B01J8/02
Filed: 2008-06-20
Abstract: The invention relates to a reactor (R) for performing a three-phase reaction of a fluid phase (1) and a gaseous phase (2) on a packed bed catalyst (F), the packed bed catalyst (F) being disposed horizontally in the reactor (R) and the fluid phase (1) and the gaseous phase (2) being fed through the reactor (R) from the bottom to the top, using a mixing and distributing device (MV) across the packed bed catalyst (F), characterized in that the mixing and distributing device (MV) comprises a trough distributor (TV) for the fluid phase (1) having trough-shaped channels (K) and drain tubes (A) in the trough-shaped channels (K) for the fluid phase (1), and a distributor floor (B) disposed below and at a distance from the trough distributor (TV) in which vertical spouts (T) are disposed, having one or more openings (P1) for the inlet of the gaseous phase (2) and one or more openings (P2) disposed below the openings (P1) for the inlet of the gaseous phase, for the inlet of the fluid phase (1) into the spouts (T), and the number and size of the openings (P2) for the inlet of the fluid phase (1) being designed such that the fluid level on the distribution floor (B) is adjusted to be below the openings (P1) for the inlet of the gaseous phase (2) and above the openings (P2) for the inlet of the fluid phase (1) for a prescribed inlet flow of fluid.
Patent CA-2695676-A1 (CA)
Inventor: ERISMANN DAVID W
IPC: C08L71/02
Filed: 2002-01-07
Abstract: An aqueous fire barrier composition including a latex that includes a polymer, a polyol having 2, 3 or 4 hydroxy groups and a molecular weight of from about 75 to about 1200, and an intumescent agent.
Patent CA-2695785-A1 (CA)
Inventor: BLAIR PAUL M
IPC: B08B1/00
Filed: 2008-10-10
Abstract: Fiber optic connector end faces are cleaned effectively by exposing the fiber optic connector end face (1) to the disclosed predominantly aqueous solution and wiping the fiber optic end face dry. The predominantly water-based cleaning solution contains water, water soluble organic solvents, propylene glycol ethers and isopropanol. Also disclosed is a method for cleaning a fiber optic end face using an aqueous solution.
Patent CA-2695950-A1 (CA)
Inventor: DALY MICHAEL J
IPC: A61K35/74
Filed: 2008-08-18
Abstract: This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In addition, the invention encompasses methods of treating and/or preventing a side effect of radiation exposure and methods of preventing a side effect of radiotherapy comprising administration of a pharmaceutically effective amount of a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese) to a subject in need thereof. The compositions may comprise D. radiodurans extracts.
Patent CA-2697043-A1 (CA)
Inventor: OH YOUNGMAN
IPC: A61P35/00
Filed: 2008-08-21
Abstract: The present invention comprises methods and compositions for the treatment or prevention of radiation-induced fibrosis. Methods and compositions for the inhibition of CTGF are disclosed herein. Methods and compositions for treatment of neoplastic disease are disclosed herein. Inhibition of CTGF in humans or animals that have been exposed to ionizing radiation results in treatment or prevention of radiation-induced fibrosis.
Patent CA-2698997-A1 (CA)
Inventor: ALTHER ROGER
IPC: B65D5/74
Filed: 2008-08-08
Abstract: The self-opening closure consists of a pouring spout (10), which can be assembled leak-proof on a combipack or on a container spout to be sealed with foil material, appropriate twist cap (9) as well as a self-opening sleeve (1) arranged inside the pouring spout (10). This can be made to rotate by the twist cap (9). The self-opening sleeve (1) forms on its upper edge an indentation (4), which becomes smaller towards the bottom edge (6) and tapers off into the same. There are guiding means present on the outer side of the self-opening sleeve (1) and on the inner side of the pouring spout (10) so that the self-opening sleeve (1) is guided downwards by the rotation on the pouring spout (10). The indentation (4) lies partially inside the pouring spout (10) and partially below the same after the unscrewing of the cover cap and forms an air inlet channel, which results in a steady outpour during the pouring out of the liquid content of a combipack.
Patent CA-2700199-A1 (CA)
Inventor: MORILLO CONNIE SANCHEZ
IPC: C07D209/20
Filed: 2008-09-24
Abstract: The present invention relates to combination therapies and pharmaceutical compositions comprising a combination of 5-hydroxytryptophan and a serotonin reuptake inhibitor that binds to an ailosteric site of the serotonin transporter. The present invention further provides a pharmaceutical composition comprising (i) 5-hydroxytryptophan in an amount ranging from about 1 mg to about 75 mg; and (ii) a serotonin reuptake inhibitor that binds to an allosteric site of the serotonin transporter.
Patent CA-2702409-A1 (CA)
Title: Removable wheel cover
Inventor: SMITH GREG
IPC: B60B7/06
Filed: 2010-04-28
Abstract: A universal wheel cover assembly for covering a variety of different vehicle's wheels. The universal wheel cover assembly comprises: (a) a covering disc sized to cover the vehicle's wheel, (b) a universal bolt pattern plate, said universal bolt pattern plate including (i) a series of sections, each of said sections having a plurality of engagement means, wherein said sections are adapted for matching a pattern of bolts disposed on the vehicle's axel hubs used for attaching the vehicle's wheel, and (ii) a retaining system for connecting the universal bolt pattern plate to the covering disc, and (c) a spring biasing base comprising of a plurality of coil units, each coil unit for coupling one bolt in the pattern of bolts to the engagement means of the universal bolt pattern plate. The removable wheel cover assembly may be used in a variety of different vehicle tire rims and is aesthetically pleasing.
Patent CA-2703608-A1 (CA)
Title: Herbicidal combination
Inventor: HACKER ERWIN
IPC: A01N57/12
Filed: 2008-10-22
Abstract: The invention relates to a herbicidal combination which contains components (A) and (B), (A) being one or more herbicides from the group consisting of 2-iodo-N-[(4- methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]benzolsulfonamide and compounds of general formula (I), wherein the cation (M+) represents (a) an ion of the alkali metals, preferably lithium, sodium, potassium, or (b) an ion of the alkaline earth metals, preferably calcium and magnesium, or (c) an ion of the transition metals, preferably manganese, copper, zinc or iron, or (d) an ammonium ion, wherein optionally one, two, three or four hydrogen atoms are substituted with the residues, which are the same or different, of the group (C1-C4)-alkyl, hydroxy-(C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, hydroxy-(C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C6)-mercaptoalkyl, phenyl or benzyl, these residues optionally being substituted with one or more residues, which are the same or different, of the group including halogen, such as F, Cl, Br or I, nitro, cyano, azido, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy and phenyl, and two substituents each at the N atom optionally forming an unsubstituted or substituted ring, or (e) a phosphonium ion, or (f) a sulfonium ion, preferably tri-((C1-C4)-alkyl)-sulfonium, or (g) an oxonium ion, preferably tri-((C1-C4)-alkyl)-oxonium, or (h) an optionally monoannulated or polyannulated and/or (C1-C4) alkyl-substituted saturated or unsaturated/aromatic N-containing heterocyclic ionic compound with 1-10 C atoms in the ring system, and (B) one or more herbicides from the group of organic phosphorus compounds consisting of: anilofos, bensulide, bilanafos, butimafos, fosamine, glufosinate, glufosinate salts, glufosinate-ammonium, glufosinate-sodium, L-glufosinate-ammonium, L-glufosinate-sodium, glyphosate, glyphosate salts, glyphosate-isopropyl-ammonium, glyphosate- ammonium, glyphosate-trimesium, glyphosate-diammonium, glyphosate-potassium, piperophos, ethephon and tribufos.
Patent CA-2704005-A1 (CA)
Inventor: GREEN STEPHEN
IPC: A61B17/08
Filed: 2008-09-05
Abstract: The present invention relates generally to medical devices and methods for sealing and closing passages formed through tissue. More specifically, the present invention relates to devices for sealing or closing an opening formed through biological tissue comprising a distal or outside margin or surface, and a proximal or inside margin or surface (i.e., a wall thickness), and to apparatuses and methods for delivering such devices, to control (or prevent or stop) bleeding (or the flow of other biological fluid or tissue).  The openings comprise percutaneously formed punctures, incisions, or other openings formed through biological tissue, such as in blood vessels, organs, and the like.
Patent CA-2705507-A1 (CA)
Inventor: TEZCAN MUSTAFA
IPC: G07C5/00
Filed: 2008-06-23
Abstract: The invention is a vehicle management device (1), which provides the connection of the vehicles with the central office for such purposes as vehicle monitoring and planning, and monitors the actions taken and/or not taken by the driver inside and/or outside the vehicle in order to aid in measuring the performance of the driver, and comprises at least one smart card slot (1.1) housing at least one smart card where said tasks are loaded, characterized in that said device (1) comprises at least one fingerprint sensor (1.3) defined specifically for the user to enable the operation of said device (1) and at least one color touch screen (1.2) positioned as the control panel for said device (1).
Patent CA-2708068-A1 (CA)
Inventor: PETITO GEORGE D
IPC: A61P27/02
Filed: 2010-06-22
Abstract: The composition and method for healing tissues is a medicinal composition for facilitating the growth, protection and healing of tissues and cells in animals and humans. The composition is formulated as a either a powder, gel, paste, film, fluid injectable, rehydratable freeze-dried paste or sponge, sprayable solution, topically applied patch with adhesive and reservoir system, an intermediate for coatables such as films and bandages, a matrix for membranes, or as a matrix of flexible polymer(s), or delivered as either an orally ingestible liquid, tablet or capsule. The main ingredient of the formulated compositions is hydrolyzed collagen, which can be combined with polysulfated glycosaminoglycans, hyaluronic acid or salts thereof, or a glucosamine salt, and mixtures thereof. The composition may be formulated as an aqueous eye drop solution.
Patent CA-2710644-A1 (CA)
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: A61K31/407
Filed: 2008-12-23
Abstract: The present invention relates to inhibitors of HCV replication of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, formula (I), wherein R1; R3; and R4 have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
Patent CA-2713407-A1 (CA)
Inventor: ABRISHAMKAR FARROKH
IPC: H04L7/04
Filed: 2009-02-20
Abstract: A method for midamble estimation comprises the steps of receiving a burst of symbols, selecting a subset of the burst of symbols that comprises a first midamble symbol, calculating, for each symbol in the subset, a corresponding mi-damble estimation error, and determining the lowest calculated midamble estima-tion error to locate the first midamble symbol. A receiver comprises an antenna configured to receive a burst of symbols, a timing estimator configured to select a subset of the burst of symbols that comprises a first midamble symbol, a midamble estimator configured to calculate, for each symbol in the subset, a corresponding midamble estimation error, and a processor configured to select the symbol in the subset corresponding to a lowest calculated midamble estimation error as the first midamble symbol.
Patent CA-2714279-A1 (CA)
Title: Materiau hybride organique-inorganique, couche mince optique de ce materiau, materiau optique les comprenant, et leur procede de fabrication
Inventor: MARCHET NICOLAS
IPC: C09D7/62
Filed: 2009-02-04
Abstract: Matériau composite organique-inorganique comprenant : des particules colloïdales d'au moins un composé inorganique choisi parmi les oxydes et oxyhydroxydes de métal ou de métalloïdes préparées par un procédé d'hydrolyse-condensation dans un solvant protique ou polaire, lesdites particules ayant été fonctionnalisées en surface par réaction avec un composé organique; et un polymère organique ou inorganique. Procédé de préparation de ce matériau composite et matériau optique comprenant une couche de ce matériau composite.
Patent CA-2714708-A1 (CA)
Title: Combinaisons et procedes pour l'administration sous-cutanee de gammaglobuline et d'hyaluronidase
Inventor: SCHIFF RICHARD
IPC: A61K39/395
Filed: 2009-03-16
Abstract: Linvention concerne des combinaisons, des compositions et des kits qui contiennent une composition de gammaglobuline (IG) et une composition dhyaluronidase soluble, formulées pour une administration sous-cutanée. De tels produits peuvent être utilisés dans des procédés de traitement de maladies ou de troubles traitables par IG. Linvention concerne également des procédés dadministration sous-cutanée de gammaglobuline, le régime de dosage étant sensiblement le même que pour ladministration intraveineuse du même dosage pour le traitement de la même maladie ou du même trouble traitable par IG.
Patent CA-2716700-A1 (CA)
Inventor: KAPSALI VERONIKA
IPC: D02G3/38
Filed: 2008-02-28
Abstract: A material has as elements, a plurality of activatable elements each having a portion fixed relative to the material and a portion free to deform relative to the material.
Patent CA-2720939-A1 (CA)
Inventor: SALMELA JUHA K
IPC: B67D7/80
Filed: 2009-04-14
Abstract: The embodiments of the present invention are directed to a dispensing apparatus for dispensing a flowable product at or above a preset elevated temperature through a dispensing outlet. Such an apparatus includes a pot in which to house the product. The dispensing apparatus also includes a pump coupled between the pot and the dispensing outlet to pump the flowable product from the pot to the dispensing outlet. A rope heater configured to heat the pot may also be included in the dispensing apparatus. The pot may have a movable lid, which may vacuum seal the product against the exterior environment. The lid is designed to scrape any food product residue off the vertical walls of the pot, while also maintaining the vacuum as it moves into the pot. The pot may have a check valve to prevent product spilling when the pot is lifted out of the housing.
Patent CA-2721632-A1 (CA)
Inventor: ROETERDINK JOHAN WILLEM
IPC: B21D41/02
Filed: 2009-04-21
Abstract: The invention relates to a method for radially expanding a container body, comprising the steps of. i) providing a cylindrical container body (1) having a longitudinal weld seam; ii) providing the container body (1) at at least one end with a flange (4); iii) clamping the container body (1) circumferentially at the flange (4) in a suspended state; and iv) radially expanding the suspended and clamped body from the clamped body end towards the suspended body end, to an apparatus (5) therefore and to the container body and container.
Patent CA-2722996-A1 (CA)
Inventor: BETHUNE MICHAEL THOMAS
IPC: C07K7/00
Filed: 2009-05-13
Abstract: The diagnosis of an enteropathic disease or the response of a patient with an enteropathic disease to therapy, in a clinical trial setting or in a long-term disease management setting, is assessed by detecting the ability of the patient to metabolize an orally administered gluten peptide analog. The peptide metabolism may be monitored in a variety of ways. Conveniently, the appearance of a metabolite of the peptide is detected in a patient sample over a period of time following oral administration, e.g. in urine, plasma, breath, saliva, etc. The gluten peptide analog is optionally labeled, e.g. with an isotopic, fluorescent, etc. label.